C. Román

发表

Differential Relaxant Responses of Guinea‐pig Lung Strips and Bronchial Rings to Sodium Nitroprusside: A Mechanism Independent of cGMP Formation

W. S. Wong, C. Román, J. Fleisch, 1995, The Journal of pharmacy and pharmacology.

Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.

N. Roehm, C. Román, J. Fleisch, 1999, The Journal of pharmacology and experimental therapeutics.

The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol class.

W. Jackson, M. Sofia, S. Silbaugh, 1997, Advances in experimental medicine and biology.

(Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists.

C. Román, J. Fleisch, F. Carr, 1991, Journal of medicinal chemistry.

Contraction of guinea pig inferior vena cava by eicosanoids

C. Román, J. Fleisch, S. Spaethe, 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647

C. Whitesitt, S. Sigmund, W. S. Marshall, 1989, Agents and Actions.

Quinoline-substituted dihydroindoles as cysLT1 (LTD4 receptor) antagonists

S. Silbaugh, J. S. Sawyer, P. Stengel, 1996 .

Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.

R. J. Boyd, R. Schultz, W. Jackson, 1999, The Journal of pharmacology and experimental therapeutics.

Leukotriene Receptor Antagonism and Augmentation of β‐Receptor‐mediated Events by LY171883 1

K. Bemis, D. Henry, W. S. Marshall, 1990 .

Acid unit modifications of 1,2,4,5-substituted hydroxyacetophenones and the effect on in vitro and in vivo LTB4 receptor antagonism

W. Jackson, M. Sofia, S. Silbaugh, 1993 .

Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist.

S. Silbaugh, T. Goodson, D. K. Herron, 1992, European journal of pharmacology.

Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.

J. L. Bobbitt, W. Jackson, E. D. Mihelich, 1996, The Journal of pharmacology and experimental therapeutics.

ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia

Todd R. Wiernicki, M. O'Neill, D. Lodge, 2000, Brain Research.